Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

Comment by Barewoodon May 05, 2018 4:15pm
117 Views
Post# 27987621

RE:Barewood

RE:BarewoodI'm assuming much of the penny flipping is beginning to dry up. Again, I'm assuming, the Conference Call is going to give us some indication of what ratio the share consolidation will be forecasted, and what progress has been made with regards to Neovasc's "turn around strategy". Analyst at this point are presenting indicators based solely on current figures prior to and up to the April 30 20-F release without any insider release of information other than that, so these indicators will change based on the 1st quarter results, nature of the beast, that being the maket's cycle. In should be an interesting week coming up.
<< Previous
Bullboard Posts
Next >>